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Abstract 
Hepatocellular adenomas (HCA) are rare benign tumors of the liver, occurring predominantly 
in females using oral contraceptives. Our case describes a 66-year-old woman presenting with 
a palpable mass in her upper abdomen. Contrast-enhanced computed tomography and mag-
netic resonance imaging showed a large exophytic mass protruding from the caudal border of 
liver segments IV and V, without visible metastases. Laparoscopic resection of the tumor and 
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gallbladder was performed. Histopathological examination showed a hepatocellular carcinoma 
with areas of HNF1a-HCA (H-HCA). This case shows that malignant transformation is possible 
in H-HCA. We present our preoperative decision-making process, as well as the role of imaging 
techniques in this rare case. © 2020 The Author(s) 
 Published by S. Karger AG, Basel 
Introduction 
Hepatocellular adenomas (HCA) are rare, benign tumors of the liver [1]. They occur pre-
dominantly in females using oral contraceptives [2, 3]. Four different subtypes of HCA have 
been described, with differing histopathological, immunopathological, and molecular charac-
teristics. Overall, HCA have a relatively low chance of about 4.2% to become malignant [4]. 
However, HCA larger than 50 mm have a hemorrhagic risk of 20–25%, as well as an increased 
risk of malignancy [5]. Usually, because of these risks, HCA of this size are removed surgically 
[4, 6]. Among the four different subtypes of HCA, beta-catenin-activated HCA are known to 
carry the highest risk of malignant transformation, while hepatocyte nuclear factor 1-alpha 
(HNF1a)-inactivated HCA (H-HCA) almost never become malignant [1].  
To aid in the understanding of the pathological mechanism behind these rare cases of H-
HCA transformation into hepatocellular carcinoma (HCC), we describe a patient with an HCC 
derived from an H-HCA. The current case has already been described as part of the study by 
Putra et al. [7]. However, their primary focus was on the histopathological and immunopatho-
logical aspects of the case series. The current case report will address the preoperative deci-
sion-making process and the role of imaging techniques in this rare case. 
Case Presentation 
A 66-year-old woman was referred to our tertiary referral center because of a liver tumor 
suspicious for malignancy. The patient did not have any known pre-existing liver disease. She 
did not use oral contraceptives. She presented at the outpatient clinic with a palpable mass in 
the right upper quadrant of the abdomen, without any other complaints. Notably, she did not 
experience any pain and was in good condition (physical status was classified as ASA2). Phys-
ical examination revealed a morbidly obese woman, BMI 35.6 kg/m2, without signs of illness 
besides the palpable mass in the right upper quadrant of the abdomen. Liver function tests 
(alanine transaminase, aspartate transaminase, alkaline phosphatase, albumin, total protein, 
bilirubin, gamma-glutamyltransferase, and prothrombin time) and tumor marker results (al-
pha fetoprotein, carcinoembryonic antigen, and carbohydrate antigen 19-9) were normal. 
Hepatitis serology was initiated and showed a history of hepatitis C and E, but there was no 
active disease confirmed by a negative viral load determined by polymerase chain reaction. 
Contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) 
showed a solitary large (about 15 × 20 cm), heterogeneous exophytic mass protruding from 
the caudal border of liver segments IV and V with a heterogeneous hypervascular enhance-
ment pattern, without clear washout in the portal venous or delayed contrast phases (Fig. 1). 
At MRI, the lesion showed a heterogeneous increased signal intensity at T2-weighted images, 
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and no intracellular fat was observed. In addition, no clear signs of steatosis, cirrhosis, or por-
tal hypertension were present, and no metastases were found. Therefore, at imaging the diag-
nosis remained unclear (Table 1), and most importantly, malignancy (such as HCC or angio-
sarcoma) could not be ruled out.  
A fibroscan was performed and showed a result of 6.0 Kpa, corresponding to F0 fibrosis, 
indicating no liver fibrosis. It also showed a controlled attenuation parameter of 310 db/m, 
corresponding to severe steatosis (hepatocytes containing fat of >66%) [8]. After combining 
all of the aforementioned results, the differential diagnosis included HCC and angiosarcoma. 
After reviewing the case in a multidisciplinary liver tumor meeting, the lesion was considered 
most likely to be an HCC in a non-cirrhotic liver. This was in particular based on its heteroge-
neous T2-hyperintensity at MRI, combined with its hypervascular aspect. Then, it was decided 
to perform a combined laparoscopic resection of the tumor and gallbladder because of the 
close relationship between tumor and gallbladder, and because of the increased technical risk 
of a cholecystectomy at a later date, should the need arise. The decision to perform surgery 
was based on the risk of malignancy, as well as size. Although the tumor was large, a radical 
resection through a laparoscopic approach seemed both possible and feasible in experienced 
hands. 
Surgical Method 
We performed a laparoscopy, with the patient in the French position. The tumor was iden-
tified, measuring about 15 × 20 cm, originating from the caudal border of liver segments IV 
and V. No signs of peritoneal deposits were seen, and the liver showed no further abnormali-
ties. A plane was established between gallbladder and tumor. Using the sealing technique and 
a tri-stapler, the tumor was dissected at the edge of the liver. The gallbladder was removed 
according to the Critical View of Safety (CVS) principles. There were no intraoperative signs 
of biliary leakage. The tumor and gallbladder were removed with an extraction bag through a 
small lower midline laparotomy. Both the tumor and the gallbladder were sent to the pathol-
ogy department for examination. The exophytic tumor weighed 1,200 g (Fig. 2a). The postop-
erative course was uneventful, and the patient was discharged after 4 days. Two weeks after 
the operation, the patient was seen at the outpatient clinic and showed complete recovery 
without any complications. 
Pathology 
Pathological findings are shown in Figure 2b. Gross examination showed a multinodular 
lesion with necrotic and hemorrhagic areas. Some non-lesional liver tissue was present at the 
resection margin. Microscopic examination confirmed hemorrhage and necrosis. The lesion 
showed the characteristics of an HCC consisting of hepatocytes arranged in trabecular and 
pseudo-glandular structures, lined by CD34-positive endothelium and apparent reticulin loss. 
The tumor hepatocytes showed extensive steatosis, some anisonucleosis, and prominent nu-
cleoli. There was no angioinvasion, and the resection margin was free from tumor. 
Between the overt HCC areas, transitions to small areas compatible with HCA were ob-
served. The HCA areas showed solitary arteries with absence of portal tracts, while reticulin 
loss, cellular atypia, or trabecular or pseudoglandular architecture were not present, together 
with a decrease in steatosis.  
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Immunohistochemistry showed absence of LFABP in both HCC and HCA whilst the non-
lesional liver tissue showed a normal diffuse expression pattern (Fig. 3). Amyloid AA and CRP 
were negative, and there was no nuclear b-catenin. Glutamine synthetase was diffusely ex-
pressed, stronger in the HCC than in the HCA. Mutational analysis showed GNAS exon 8 muta-
tion in both HCA and HCC components. 
Discussion 
In this report, we have shown malignant transformation of H-HCA into HCC. In contrast 
to beta catenin-activated HCA, H-HCA has been very infrequently associated with malignancy 
and is the predominant type of HCA in liver adenomatosis. In patients with hepatic adenoma-
tosis, H-HCA is most frequently seen [9]. The European Association for the Study of the Liver 
(EASL) guidelines, concerning benign liver tumors, currently recommend basing the manage-
ment of patients with multiple HCA upon the size of the largest tumor [6]. Individuals with 
unilobular disease can be treated with hepatic resection, and for those with more widespread 
HCA, resection of the largest adenomas may be an option. Another method to achieve mass 
reduction of adenomas is embolization. In the most severe cases, resection of all large masses 
is not possible, and a liver transplantation should be considered an option. Our case supports 
the resection of large tumors suspected to be either HCA or HCC, since even H-HCA is now 
proven to carry a risk of malignant transformation, a quality that was still under debate. 
In conclusion, malignant transformation of H-HCA into HCC is a rare entity that should be 
considered in patients with liver tumors measuring >50 mm. When encountered, laparoscopic 
resection of an exophytic mass is feasible. 
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Fig. 1. CT and MRI of the exophytic liver tumor. a Coronal contrast-enhanced CT image of the abdomen at 
the portal venous phase showing the large exophytic mass originating from the caudal border of liver seg-
ments 4B and 5 with a heterogeneous enhancement pattern. b Axial fat-suppressed T2-weighted MR image 
showing the large tumor with heterogeneous hyperintense signal intensity. c–e Axial fat-suppressed T1-
weighted MR images at the arterial (c), portal venous (d), and delayed phase (e), showing slight heteroge-
neous, predominantly peripheral arterial enhancement, with increasing enhancement at the portal venous 
and delayed phases. No significant drop of signal intensity was present at the opposed-phase T1-weighted 
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Fig. 2. Macroscopic aspect. Fresh resection specimen whole (a) and sliced (b). Almost the whole specimen 
was lesional and consisted of a multinodular tumor with partial myxoid/necrotic aspect and partial cap-
sule formation. The different nodules were microscopically not clearly demarcated in HCC or adenoma, 
with an intimate mixture of the two components. Microscopic aspect. c Both components present, with the 
HCC component on top of the image and the adenomatous component at the bottom. The HCC is charac-
terized by trabecular and pseudoglandular structures, while the adenomatous component consists of 
atrophic hepatocytes with some sinusoidal dilatation while unpaired arteries are present and portal tracts 
are absent (HE. ×10). d The same area in the reticulin stain. Note the disrupted reticulin framework and 
the thickened pseudoglandular structures in the HCC component, while the reticulin framework is pre-
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Fig. 3. Microscopic aspect with staining. Images were acquired through digital pathology. Objective is 
shown. a CD34 control staining at ×5. b CD34 staining at ×5. c LFABP control staining at ×5. d LFABP stain-
ing of the HCC at ×10. e LFABP staining of the border between lesional and non-lesional tissue at ×1.  
f Amyloid-AA staining with control at ×1. g CRP staining at ×5. h CRP control staining at ×10. i Beta-catenin 
control staining at ×10. j Beta-catenin staining at ×10. k Glutamine staining at ×5. l Glutamine control stain-
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Table 1. Interpretation of findings on CT and MRI 
   
   
Findings HCC HCA 
   
   
Large, heterogeneous lesion + +/– 
Increased signal intensity at T2-weighted images + – 
Absence of intracellular fat +/– – 
Absence of cirrhosis +/– + 
No washout in the portal venous or delayed contrast phases – + 
   
   
+, increases suspicion; –, decreases suspicion.   
   
   
 
 
 
